SEARCH

SEARCH BY CITATION

References

  • Agamanolis D. P. (2005) Metabolic and toxic disorders, in Neuropathology (PraysonR. A., ed.), pp. 339420. Elsevier, Amsterdam.
  • Ahlemeyer B., Hühne R. and Krieglstein J. (2000) Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J. Neurosci. Res. 60, 767778.
  • Akeson A. L., Woods C. W., Mosher L. B., Thomas C. E. and Jackson R. L. (1991) Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 86, 261270.
  • Alroy I., Towers T. L. and Freedman L. P. (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15, 57895799.
  • Anderson P. (2008) Post-transcriptional control of cytokine production. Nat. Immunol. 9, 353359.
  • Angelillo-Scherrer A., Burnier L., Lambrechts D. et al. (2008) Role of Gas6 in erythropoiesis and anemia in mice. J. Clin. Invest. 118, 583596.
  • Asirvatham A. J., Magner W. J. and Tomasi T. B. (2009) miRNA regulation of cytokine genes. Cytokine 45, 5869.
  • Austenaa L. M., Carlsen H., Ertesvag A., Alexander G., Blomhoff H. K. and Blomhoff R. (2004) Vitamin A status significantly alters nuclear factor-κB activity assessed by in vivo imaging. FASEB J. 18, 12551257.
  • Au-Yeung K. K., Woo C. W., Sung F. L., Yip J. C., Siow Y. L. and Karmin O. (2004) Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ. Res. 94, 2836.
  • Au-Yeung K. K., Yip J. C., Siow Y. L. and Karmin O. (2006) Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages. Can. J. Physiol. Pharmacol. 84, 141147.
  • Azzi A. and Stocker A. (2000) Vitamin E: non-antioxidant roles. Prog. Lipid Res. 39, 231255.
  • Azzi A., Gysin R., Kempná P., Munteanu A., Villacorta L., Visarius T. and Zingg J. M. (2004) Regulation of gene expression by α-tocopherol. Biol. Chem. 385, 585591.
  • Bâ A. (2008) Metabolic and structural role of thiamine in nervous tissues. Cell. Mol. Neurobiol. 28, 923931.
  • Baas D., Prüfer K., Ittel M. E., Kuchler-Bopp S., Labourdette G., Sarliève L. L. and Brachet P. (2000) Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25-dihydroxyvitamin D3. GLIA 31, 5968.
  • Ballow M., Xiang S., Greenberg S. J., Brodsky L., Allen C. and Rich G. (1997) Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells. Int. Arch. Allergy Immunol. 113, 167169.
  • Balmer J. E. and Blomhoff R. (2002) Gene expression regulation by retinoic acid. J. Lipid Res. 43, 17731808.
  • Banks W. A. (2005) Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 11, 973984.
  • Basu T. K., Makhani N. and Sedgwick G. (2002) Niacin (nicotinic acid) in non-physiological doses causes hyperhomocysteineaemia in Sprague-Dawley rats. Br. J. Nutr. 87, 115119.
  • Batova A., Danielpour D., Pirisi L. and Creek K. E. (1992) Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ. 3, 763772.
  • Bauer S., Kerr B. J. and Patterson P. H. (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 8, 221232.
  • Bender D. A. (2003) Nutritional Biochemistry of the Vitamins, 2nd edn. Cambridge University Press, Cambridge.
  • Bendich A. and Butterworth C. E. Jr (1991) Micronutrients in Health and Disease Prevention. Marcel Dekker Inc., New York.
  • Benveniste E. N., Nguyen V. T. and Wesemann D. R. (2004) Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav. Immun. 18, 712.
  • Bhalla A. K., Amento E. P. and Krane S. M. (1986) Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98, 311322.
  • Bikle D. (2009) Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 94, 2634.
  • Blackwell T. S. and Christman J. W. (1997) The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17, 39.
  • Blomhoff R. and Blomhoff H. K. (2006) Overview of retinoid metabolism and function. J. Neurobiol. 66, 606630.
  • Booth S. L. (1997) Skeletal functions of vitamin K-dependent proteins: not just for clotting anymore. Nutr. Rev. 55, 282284.
  • Bouillon R. (2006) Vitamin D: from photosynthesis, metabolism, and action to clinical applications, in Endocrinology, 5th edn (DeGrootL. J. and JamesonJ. L., eds), vol. 2, pp. 14351463. Elsevier, Philadelphia.
  • Bourre J. M. (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10, 377385.
  • Bowie A. G. and O’Neill L. A. (2000) Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol. 165, 71807188.
  • Brigelius-Flohé R. (2009) Vitamin E: the shrew waiting to be tamed. Free Radic. Biol. Med. 46, 543554.
  • Brown A. J., Dusso A. and Slatopolsky E. (1999) Vitamin D. Am. J. Physiol. Renal Physiol. 277, F157F175.
  • Brunaud L., Alberto J. M., Ayav A. et al. (2003) Vitamin B12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion 68, 133140.
  • Buccellato F. R., Miloso M., Braga M., Nicolini G., Morabito A., Pravettoni G., Tredici G. and Scalabrino G. (1999) Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α mediated. FASEB J. 13, 297304.
  • Buck I., Morceau F., Cristofanon S., Reuter S., Dicato M. and Diederich M. (2009) The inhibitory effect of the proinflammatory cytokine TNFα on erythroid differentiation involves erythroid transcription factor modulation. Int. J. Oncol. 34, 853860.
  • Calfee-Mason K. G., Spear B. T. and Glauert H. P. (2002) Vitamin E inhibits hepatic NF-κB activation in rats administered the hepatic tumor promoter, phenobarbital. J. Nutr. 132, 31783185.
  • Cantorna M. T. (2000) Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223, 230233.
  • Cantorna M. T., Nashold F. E. and Hayes C. E. (1995) Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 25, 16731679.
  • Cantorna M. T., Nashold F. E., Chun T. Y. and Hayes C. E. (1996a) Vitamin A down-regulation of IFN-γ synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J. Immunol. 156, 26742679.
  • Cantorna M. T., Hayes C. E. and DeLuca H. F. (1996b) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl Acad. Sci. USA 93, 78617864.
  • Cantorna M. T., Woodward W. D., Hayes C. E. and DeLuca H. F. (1998) 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-β1 and IL-4. J. Immunol. 160, 53145319.
  • Cantorna M. T., Zhu Y., Froicu M. and Wittke A. (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80(Suppl. 6), S1717S1720.
  • Cárcamo J. M., Pedraza A., Bórquez-Ojeda O. and Golde D. W. (2002a) Vitamin C suppresses TNFα-induced NFκB activation by inhibiting IκBα phosphorylation. Biochemistry 41, 1299513002.
  • Cárcamo J. M., Bórquez-Ojeda O. and Golde D. W. (2002b) Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood 99, 32053212.
  • Carluccio M. A., Ancora M. A., Massaro M., Carluccio M., Scoditti E., Distante A., Storelli C. and De Caterina R. (2007) Homocysteine induces VCAM-1 gene expression through NF-κB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am. J. Physiol. Heart. Circ. Physiol. 293, H2344H2354.
  • Casaccia-Bonnefil P., Pandozy G. and Mastronardi F. (2008) Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis. Prog. Neurobiol. 86, 368378.
  • Chang M. M., Harper R., Hyde D. M. and Wu R. (2000) A novel mechanism of retinoic acid-enhanced interleukin-8 gene expression in airway epithelium. Am. J. Respir. Cell Mol. Biol. 22, 502510.
  • Chasis J. A. and Mohandas N. (2008) Erythroblastic islands: niches for erythropoiesis. Blood 112, 470478.
  • Chatterjee M. (2001) Vitamin D and genomic stability. Mutat. Res. 475, 6987.
  • Chattopadhyay N., Butters R. R. and Brown E. M. (2001) Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res. Mol. Brain Res. 87, 100108.
  • Chen A., Davis B. H., Sitrin M. D., Brasitus T. A. and Bissonnette M. (2002) Transforming growth factor-β1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G864G874.
  • Cheung P. and Lau P. (2005) Epigenetic regulation by histone methylation and histone variants. Mol. Endocrinol. 19, 563573.
  • Chitnis T. and Khoury S. J. (2003) Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol. Res. 28, 233239.
  • Claycombe K. J. and Meydani S. N. (2001) Vitamin E and genome stability. Mutat. Res. 475, 3744.
  • Cobianchi L., Fornoni A., Pileggi A. et al. (2008) Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant. 17, 559566.
  • Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C. and Douvdevani A. (2006) Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol. Dial. Transplant. 21, 889897.
  • Cohen-Lahav M., Douvdevani A., Chaimovitz C. and Shany S. (2007) The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J. Steroid Biochem. Mol. Biol. 103, 558562.
  • Collins A. R. (2001) Carotenoids and genomic stability. Mutat. Res. 475, 2128.
  • Combs G. F. Jr (1998) The Vitamins. Academic Press San Diego, California.
  • Cornet A., Baudet C., Neveu I., Baron-Van Evercooren A., Brachet P. and Naveilhan P. (1998) 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J. Neurosci. Res. 53, 742746.
  • Cranenburg E. C., Schurgers L. J. and Vermeer C. (2007) Vitamin K: the coagulation vitamin that became omnipotent. Thromb. Haemost. 98, 120125.
  • Cutroneo K. R. (2007) TGF-β-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 15(Suppl. 1), S54S60.
  • D’Ambrosio D., Cippitelli M., Cocciolo M. G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F. and Panina-Bordignon P. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. J. Clin. Invest. 101, 252262.
  • Dakshinamurti K. (2005) Biotin--a regulator of gene expression. J. Nutr. Biochem. 16, 419423.
  • Dalal S., Parkin S. M., Homer-Vanniasinkam S. and Nicolaou A. (2003) Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann. Clin. Biochem. 40, 534541.
  • Danielpour D. (1996) Induction of transforming growth factor-β autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J. Cell. Physiol. 166, 231239.
  • Deadwyler G. D., Pouly S., Antel J. P. and Devries G. H. (2000) Neuroregulins and erbB receptor expression in adult human oligodendrocytes. GLIA 32, 304312.
  • Delves P. J., Martin S. J., Burton D. R. and Roitt I. M. (2006) Control mechanisms, in Roitt’s Essential Immunology, 11th edn., pp. 211228. Blackwell Publishing Ltd, Oxford.
  • Denisova N. A. and Booth S. L. (2005) Vitamin K and sphingolipid metabolism: evidence to date. Nutr. Rev. 63, 111121.
  • Denu J. M. (2005) Vitamin B3 and sirtuin function. Trends Biochem. Sci. 30, 479483.
  • Devaraj S., Li D. and Jialal I. (1996) The effects of alpha tocopherol supplementation on monocyte function. J. Clin. Invest. 98, 756763.
  • Diaz B. V., Lenoir M. C., Ladoux A., Frelin C., Démarchez M. and Michel S. (2000) Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642650.
  • Diaz-Arrastia R. (2000) Homocysteine and neurologic disease. Arch. Neurol. 57, 14221428.
  • Dong X., Craig T., Xing N., Bachman L. A., Paya C. V., Weih F., McKean D. J., Kumar R. and Griffin M. D. (2003) Direct transcriptional regulation of RelB by 1α,25-dihydroxyvitamin D3 and its analogs. J. Biol. Chem. 278, 4937849385.
  • Estey E. H. and Kantarjian H. M. (2005) Therapy for acute myeloid leukemia, in Hematology (HoffmanR., BenzE. J.Jr, ShattilS. J., FurieB., CohenH. J., SilbersteinL. E. and McGlaveP., eds), pp. 10991120. Elsevier Inc, Philadelphia.
  • Falkenstein E., Tillmann H. C., Christ M., Feuring M. and Wehling M. (2000) Multiple actions of steroid hormones- a focus on rapid, nongenomic effects. Pharmacol. Rev. 52, 513556.
  • Farach-Carson M. C. and Ridall A. L. (1998) Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am. J. Kidney Dis. 31, 729742.
  • Fenech M. (2001) The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat. Res. 475, 5767.
  • Feng J., Fouse S. and Fan G. (2007) Epigenetic regulation of neural gene expression and neuronal function. Pediatr. Res. 61, R58R63.
  • Ferland G. (1998) The vitamin K-dependent proteins: an update. Nutr. Rev. 56, 223230.
  • Fernández-Fernández L., Bellido-Martín L. and García de Frutos P. (2008) Growth arrest-specific gene 6 (GAS6). Thromb. Haemost. 100, 604610.
  • Finkel T., Deng C. X. and Mostoslavsky R. (2009) Recent progress in the biology and physiology of sirtuins. Nature 460, 587591.
  • Finnell R. H., Shaw G. M., Lammer E. J. and Rosenquist T. H. (2008) Gene-nutrient interactions: importance of folic acid and vitamin B12 during early embryogenesis. Food Nutr. Bull. 29(Suppl. 2), S86S98.
  • Funakoshi H., Yonemasu T., Nakano T., Matumoto K. and Nakamura T. (2002) Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons. J. Neurosci. Res. 68, 150160.
  • Furman I., Baudet C. and Brachet P. (1996) Differential expression of M-CSF, LIF, and TNF-α genes in normal and malignant rat glial cells: regulation by lipopolysaccharide and vitamin D. J. Neurosci. Res. 46, 360366.
  • Garcia A. and Zanibbi K. (2004) Homocysteine and cognitive function in elderly people. Can. Med. Ass. J. 171, 897904.
  • Garcion E., Wion-Barbot N., Montero-Menei C. N., Berger F. and Wion D. (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13, 100105.
  • Giri S. N., Gurujeyalakshmi G. and Wang Y. (2000) Suppression of bleomycin-induced increased production of nitric oxide and NF-κB activation by treatment with taurine and niacin. Adv. Exp. Med. Biol. 483, 545561.
  • Gopalakrishnan S., Van Emburgh B. O. and Robertson K. D. (2008) DNA methylation in development and human disease. Mutat. Res. 647, 3038.
  • Gurujeyalakshmi G., Hollinger M. A. and Giri S. N. (1998) Regulation of transforming growth factor-β1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. Am. J. Respir. Cell Mol. Biol. 18, 334342.
  • Gurujeyalakshmi G., Wang Y. and Giri S. N. (2000) Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-κB in mice. J. Pharmacol. Exp. Ther. 293, 8290.
  • Harant H., Andrew P. J., Reddy G. S., Foglar E. and Lindley I. J. (1997) 1α,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-κB-mediated interleukin-8 gene expression. Eur. J. Biochem. 250, 6371.
  • Harding A. E., Muller D. P., Thomas P. K. and Willison H. J. (1982) Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann. Neurol. 12, 419424.
  • Härtel C., Strunk T., Bucsky P. and Schultz C. (2004) Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 27, 101106.
  • Haugen J. D., Pittelkow M. R., Zinsmeister A. R. and Kumar R. (1996) 1α,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor β2 release. Biochem. Biophys. Res. Commun. 229, 618623.
  • Haussler M. R., Jurutka P. W., Hsieh J. C., Thompson P. D., Selznick S. H., Haussler C. A. and Whitfield G. K. (1995) New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 17(Suppl. 2), S33S38.
  • Hazell A. S. and Butterworth R. F. (2009) Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol. 44, 141147.
  • Hiremath G. S., Cettomai D., Baynes M., Ratchford J. N., Newsome S., Harrison D., Kerr D., Greenberg B. M. and Calabresi P. A. (2009) Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Mult. Scler. 15, 735740.
  • Hsieh J. and Gage F. H. (2005) Chromatin remodeling in neural development and plasticity. Curr. Opin. Cell Biol. 17, 664671.
  • Husson M., Enderlin V., Alfos S., Boucheron C., Pallet V. and Higueret P. (2004) Expression of neurogranin and neuromodulin is affected in the striatum of vitamin A-deprived rats. Mol. Brain Res. 123, 717.
  • Ito M., Sakai Y., Furumoto M., Segawa H., Haito S., Yamanaka S., Nakamura R., Kuwahata M. and Miyamoto K. (2005) Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am. J. Physiol. Endocrinol. Metab. 288, E1101E1109.
  • Jeffery C. J. (2003) Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19, 415417.
  • Kalra S., Ahuja R., Mutti E., Veber D., Seetharam S., Scalabrino G. and Seetharam B. (2007) Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs. Arch. Biochem. Biophys. 463, 128132.
  • Kaltschmidt B., Widera D. and Kaltschmidt C. (2005) Signaling via NF-κB in the nervous system. Biochim. Biophys. Acta 1745, 287299.
  • Kaput J. and Rodriguez R. L. (2004) Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16, 166177.
  • Ke Z. J. and Gibson G. E. (2004) Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem. Int. 45, 361369.
  • Ke Z. J., DeGiorgio L. A., Volpe B. T. and Gibson G. E. (2003) Reversal of thiamine deficiency-induced neurodegeneration. J. Neuropathol. Exp. Neurol. 62, 195207.
  • Ke Z. J., Calingasan N. Y., DeGiorgio L. A., Volpe B. T. and Gibson G. E. (2005a) CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem. Int. 47, 204215.
  • Ke Z. J., Calingasan N. Y., Karuppagounder S. S., DeGiorgio L. A., Volpe B. T. and Gibson G. E. (2005b) CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. J. Neuroimmunol. 164, 8592.
  • Khabar K. S. (2007) Rapid transit in the immune cells: the role of mRNA turnover regulation. J. Leukoc. Biol. 81, 13351344.
  • Khanna S., Roy S., Parinandi N. L., Maurer M. and Sen C. K. (2006) Characterization of the potent neuroprotective properties of the natural vitamin E α-tocotrienol. J. Neurochem. 98, 14741486.
  • Kirkland J. B. (2009) Niacin status and treatment-related leukemogenesis. Mol. Cancer Ther. 8, 725732.
  • Kirkland J. B., Zempleni J., Buckles L. K. and Christman J. K. (2007) Vitamin-dependent modifications of chromatin: epigenetic events and genomic stability, in Handbook of Vitamins, 4th edn., (ZempleniJ., RuckerR. B., McCormickD. B. and SuttieJ. W., eds), pp. 521544. CRC Press, Boca Raton.
  • Klass B. R., Grobbelaar A. O. and Rolfe K. J. (2009) Transforming growth factor β1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad. Med. J. 85, 914.
  • Klose R. J. and Bird A. P. (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31, 8997.
  • Kodama K., Suzuki M., Toyosawa T. and Araki S. (2005) Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice. Life Sci. 78, 134139.
  • Kolek O. I., Hines E. R., Jones M. D., LeSueur L. K., Lipko M. A., Kiela P. R., Collins J. F., Haussler M. R. and Ghishan F. K. (2005) 1α,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1036G1042.
  • Koli K. and Keski-Oja J. (1995) 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res. 55, 15401546.
  • Kouzarides T. (2007) Chromatin modifications and their function. Cell 128, 693705.
  • Krieglstein K. and Krieglstein J. (1998) Transforming growth factor-β signaling and neuroprotection, in Neuroprotective Signal Transduction (MattsonM. P., ed.), pp. 119144. Humana Press, New Jersey.
  • Kronenberg G., Colla M. and Endres M. (2009) Folic acid, neurodegenerative and neuropsychiatric disease. Curr. Mol. Med. 9, 315323.
  • Kumar N. (2007) Nutritional neuropathies. Neurol. Clin. 25, 209255.
  • Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T. and Suzumura A. (2006) The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 1116, 1218.
  • Kuroishi T., Endo Y., Muramoto K. and Sugawara S. (2008) Biotin deficiency up-regulates TNF-α production in murine macrophages. J. Leukoc. Biol. 83, 912920.
  • Lahav Cohen M., Douvdevani A., Chaimovitz C. and Shany S. (2001) Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int. 59, 6975.
  • Lane M. A. and Bailey S. J. (2005) Role of retinoid signalling in the adult brain. Prog. Neurobiol. 75, 275293.
  • Lanske B. and Razzaque M. S. (2007) Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr. Opin. Nephrol. Hypertens. 16, 311318.
  • Le Grusse J. and Watier B. (1995) Les Vitamines. Centre d’etude et information sur les vitamins (CEIV), France.
  • Le P. T., Lazorick S., Whichard L. P., Haynes B. F. and Singer K. H. (1991) Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor a regulate mRNA levels of interleukin 1α (IL-1α), IL-1β and IL-6 in human thymic epithelial cells at a post-transcriptional level. J. Exp. Med. 174, 11471157.
  • Lemire J. M. (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 53, 599602.
  • Lemire J. M. and Archer D. C. (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87, 11031107.
  • Li R., Chen J., Hammonds G. et al. (1996) Identification of Gas6 as a growth factor for human Schwann cells. J. Neurosci. 16, 20122019.
  • Liesveld J. L. and Lichtman M. A. (2006) Acute myelogenous leukemia, in Williams Hematology, 7th edn (LichtmanM. A., BeutlerE., KippsT. J., SeligsohnU., KaushanskyK. and PrchalJ. T., eds), pp. 11831236. McGraw-Hill, London.
  • Lin Y., Huang R., Santanam N., Liu Y. G., Parthasarathy S. and Huang R. P. (2002) Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett. 187, 1724.
  • Lösel R. M., Falkenstein E., Feuring M., Schultz A., Tillmann H. C., Rossol-Haseroth K. and Wehling M. (2003) Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 9651016.
  • Lukusa T. and Fryns J. P. (2008) Human chromosome fragility. Biochim. Biophys. Acta 1779, 316.
  • Lyakhovich A., Aksenov N., Pennanen P., Miettinen S., Ahonen M. H., Syvälä H., Ylikomi T. and Tuohimaa P. (2000) Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells. Biochem. Biophys. Res. Commun. 273, 675680.
  • Macián F., López-Rodríguez C. and Rao A. (2001) Partners in transcription: NFAT and AP-1. Oncogene 20, 24762489.
  • Mahmood R., Flanders K. C. and Morriss-Kay G. M. (1992) Interactions between retinoids and TGF βs in mouse morphogenesis. Development 115, 6774.
  • Mangoni A. A. (2006) Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials? Clin. Chim. Acta 367, 1119.
  • Manolagas S. C., Provvedini D. M. and Tsoukas C. D. (1985) Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol. Cell. Endocrinol. 43, 113122.
  • Marguerite V., Beri-Dexheimer M., Ortiou S., Guéant J. L. and Merten M. (2007) Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells. Cell. Physiol. Biochem. 20, 967976.
  • Martens J.-H., Barg H., Warren M. J. and Jahn D. (2002) Microbial production of vitamin B12. Appl. Microbiol. Biotechnol. 58, 275285.
  • Martínez-Frías M. L. (2008) The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome. Am. J. Med. Genet. 146A, 14771482.
  • Matsumoto K., Gaetano C., Daughaday W. H. and Thiele C. J. (1992) Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology 130, 36693676.
  • Mattick J. S. and Makunin I. V. (2005) Small regulatory RNAs in mammals. Hum. Mol. Genet. 14, R121R132.
  • Mattson M. P. and Shea T. B. (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137146.
  • Mehler M. F. (2008a) Epigenetics and the nervous system. Ann. Neurol. 64, 602617.
  • Mehler M. F. (2008b) Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 86, 305341.
  • Mey J. (2001) Retinoic acid as a regulator of cytokine signaling after nerve injury. Z. Naturforsch. 56c, 163176.
  • Mey J. (2006) New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J. Neurobiol. 66, 757779.
  • Minghetti P. P. and Norman A. W. (1988) 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 2, 30433053.
  • Molloy A. M. and Weir D. G. (2001) Homocysteine and the nervous system, in Homocysteine in Health and Disease (CarmelR. and JacobsenD. W., eds), pp. 183187. Cambridge University Press, Cambridge.
  • Molloy A. M., Kirke P. N., Troendle J. F., Burke H., Sutton M., Brody L. C., Scott J. M. and Mills J. L. (2009) Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123, 917923.
  • Montecino M., Stein G. S., Stein J. L., Lian J. B., Van Wijnen A. J., Carvallo L., Marcellini S., Cruzat F. and Arriagada G. (2008) Vitamin D control of gene expression: temporal and spatial parameters for organization of the regulatory machinery. Crit. Rev. Eukaryot. Gene Expr. 18, 163172.
  • Morante M., Sandoval J., Gómez-Cabrera M. C., Rodríguez J. L., Pallardó F. V., Viña J. R., Torres L. and Barber T. (2005) Vitamin E deficiency induces liver nuclear factor-κB DNA-binding activity and changes in related genes. Free Radic. Res. 39, 11271138.
  • Müller K. and Bendtzen K. (1996) 1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J. Investig. Dermatol. Symp. Proc. 1, 6871.
  • Müller K., Diamant M. and Bendtzen K. (1991) Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol. Lett. 28, 115120.
  • Müller K., Haahr P. M., Diamant M., Rieneck K., Kharazmi A. and Bendtzen K. (1992) 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506512.
  • Müller K., Ødum N. and Bendtzen K. (1993) 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol. Lett. 35, 177182.
  • Müller M. and Kersten S. (2003) Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4, 315322.
  • Muñoz E., Blázquez M. V., Ortiz C., Gomez-Díaz C. and Navas P. (1997) Role of ascorbate in the activation of NF-κB by tumour necrosis factor-α in T-cells. Biochem. J. 325, 2328.
  • Muraoka R. S., Waltz S. E. and Degen S. J. (1999) Expression of hepatocyte growth factor-like protein is repressed by retinoic acid and enhanced by cyclic adenosine 3′,5′-monophosphate response element-binding protein (CREB)-binding protein (CBP). Endocrinology 140, 187196.
  • Murphy K., Travers P. and Walport M. (2008) Manipulation of immune response, in Janeway’s Immunobiology, 7th edn, pp. 655–708. Garland Science, Taylor & Francis Group, New York.
  • Mutch D. M., Wahli W. and Williamson G. (2005) Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J. 19, 16021616.
  • Na S. Y., Kang B. Y., Chung S. W., Han S. J., Ma X., Trinchieri G., Im S. Y., Lee J. W. and Kim T. S. (1999) Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFκB. J. Biol. Chem. 274, 76747680.
  • Nagpal S., Na S. and Rathnachalam R. (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26, 662687.
  • Nakao M., Hironaka S., Harada N. et al. (2009) Cobalamin deficiency results in an abnormal increase in L-methylmalonyl-co-enzyme-A mutase expression in rat liver and COS-7 cells. Br. J. Nutr. 101, 492498.
  • Naveilhan P., Neveu I., Wion D. and Brachet P. (1996) 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7, 21712175.
  • Navikas V. and Link H. (1996) Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45, 322333.
  • Nelson J. S., Fitch C. D., Fischer V. W., Broun G. O. Jr and Chou A. C. (1981) Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys. J. Neuropathol. Exp. Neurol. 40, 166186.
  • Neveu I., Naveilhan P., Baudet C., Brachet P. and Metsis M. (1994a) 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6, 124126.
  • Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca H. F. and Brachet P. (1994b) 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res. Mol. Brain Res. 24, 7076.
  • Nguyen T. T., Hayakawa T. and Tsuge H. (2001) Effect of vitamin B6 deficiency on the synthesis and accumulation of S-adenosylhomocysteine and S-adenosylmethionine in rat tissues. J. Nutr. Sci. Vitaminol. 47, 188194.
  • Obeid R. and Herrmann W. (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580, 29943005.
  • Oltean S. and Banerjee R. (2003) Nutritional modulation of gene expression and homocysteine utilization by vitamin B12. J. Biol. Chem. 278, 2077820784.
  • Oltean S. and Banerjee R. (2005) A B12-responsive internal ribosome entry site (IRES) element in human methionine synthase. J. Biol. Chem. 280, 3266232668.
  • Omay S. B., Nakai K., Kuno T., Shiku H. and Nishikawa M. (1996) 1 α,25-dihydroxyvitamin D3-induced upregulation of calcineurin during leukemic HL-60 cell differentiation. Blood 87, 29472955.
  • Ooi L. and Wood I. C. (2008) Regulation of gene expression in the nervous system. Biochem. J. 414, 327341.
  • Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R. and Poli G. (1992) Vitamin E dietary supplementation inhibits transforming growth factor β1 gene expression in the rat liver. FEBS Lett. 308, 267270.
  • Pentschew A. and Schwarz K. (1962) Systemic axonal dystrophy in vitamin E deficient adult rats. Acta Neurophatol. 1, 313334.
  • Peracchi M., Bamonti Catena F., Pomati M., De Franceschi M. and Scalabrino G. (2001) Human cobalamin deficiency: alterations in serum tumour necrosis factor-α and epidermal growth factor. Eur. J. Haematol. 67, 123127.
  • Prabhu Anand S., Selvaraj P. and Narayanan P. R. (2009) Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-γ and TNF-α positive T cell subsets in pulmonary tuberculosis. Cytokine 45, 105110.
  • Probst A. V., Dunleavy E. and Almouzni G. (2009) Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 10, 192206.
  • Quan N. and Banks W. A. (2007) Brain-immune communication pathways. Brain Behav. Immun. 21, 727735.
  • Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E. and Licastro F. (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82, 636643.
  • Reichel H., Koeffler H. P., Tobler A. and Norman A. W. (1987) 1α,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl Acad. Sci. USA 84, 33853389.
  • Richard G. (2004) Molecular genetics of the ichthyoses. Am. J. Med. Genet. C (Semin. Med. Genet.) 131C, 3244.
  • Richards E. J. (2006) Inherited epigenetic variation--revisiting soft inheritance. Nat. Rev. Genet. 7, 395401.
  • Rigby W. F., Denome S. and Fanger M. W. (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. J. Clin. Invest. 79, 16591664.
  • Riis J. L., Johansen C., Gesser B., Møller K., Larsen C. G., Kragballe K. and Iversen L. (2004) 1α,25(OH)2D3 regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression. Arch. Dermatol. Res. 296, 195202.
  • Rodriguez-Melendez R. and Zempleni J. (2003) Regulation of gene expression by biotin. J. Nutr. Biochem. 14, 680690.
  • Rodriguez-Melendez R., Camporeale G., Griffin J. B. and Zempleni J. (2003) Interleukin-2 receptor-γ-dependent endocytosis depends on biotin in Jurkat cells. Am. J. Physiol. Cell Physiol. 284, C415C421.
  • Rosenberg S. S., Ng B. K. and Chan J. R. (2006) The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol. 16, 288294.
  • Roy S., Lado B. H., Khanna S. and Sen C. K. (2002) Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 530, 1723.
  • Rusnak F. and Mertz P. (2000) Calcineurin: form and function. Physiol. Rev. 80, 14831521.
  • Salbert G., Fanjul A., Piedrafita F. J., Lu X. P., Kim S. J., Tran P. and Pfahl M. (1993) Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity. Mol. Endocrinol. 7, 13471356.
  • Samuel S. and Sitrin M. D. (2008) Vitamin D’s role in cell proliferation and differentiation. Nutr. Rev. 66(Suppl. 2), S116S124.
  • Sanchez B., Lopez-Martin E., Segura C., Labandeira-Garcia J. L. and Perez-Fernandez R. (2002) 1,25-Dihydroxyvitamin D3 increases striatal GDNF mRNA and protein expression in adult rats. Mol. Brain Res. 108, 143146.
  • Saporito M. S., Brown E. R., Hartpence K. C., Wilcox H. M., Vaught J. L. and Carswell S. (1994) Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res. 633, 189196.
  • Scalabrino G. (2001) Subacute combined degeneration one century later. The neurotrophic action of cobalamin (vitamin B12) revisited. J. Neuropathol. Exp. Neurol. 60, 109120.
  • Scalabrino G. (2005) Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp. Neurol. 192, 463479.
  • Scalabrino G. (2009) The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency. Prog. Neurobiol. 88, 203220.
  • Scalabrino G. and Peracchi M. (2006) New insights into the pathophysiology of cobalamin deficiency. Trends Mol. Med. 12, 247254.
  • Scalabrino G., Buccellato F. R., Tredici G., Morabito A., Lorenzini E. C., Allen R. H. and Lindenbaum J. (1997) Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp. Neurol. 144, 258265.
  • Scalabrino G., Nicolini G., Buccellato F. R., Peracchi M., Tredici G., Manfridi A. and Pravettoni G. (1999) Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B12 (cobalamin) in the rat central nervous system. FASEB J. 13, 20832090.
  • Scalabrino G., Tredici G., Buccellato F. R. and Manfridi A. (2000) Further evidence for the involvement of epidermal growth factor in the signaling pathway of vitamin B12 (cobalamin) in the rat central nervous system. J. Neuropathol. Exp. Neurol. 59, 808814.
  • Scalabrino G., Corsi M. M., Veber D., Buccellato F. R., Pravettoni G., Manfridi A. and Magni P. (2002) Cobalamin (vitamin B12) positively regulates interleukin-6 levels in rat cerebrospinal fluid. J. Neuroimmunol. 127, 3743.
  • Scalabrino G., Carpo M., Bamonti F. et al. (2004) High tumor necrosis factor-α levels in cerebrospinal fluid of cobalamin-deficient patients. Ann. Neurol. 56, 886890.
  • Scalabrino G., Mutti E., Veber D., Aloe L., Corsi M. M., Galbiati S. and Tredici G. (2006) Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency. Neurosci. Lett. 396, 153158.
  • Scalabrino G., Veber D. and Mutti E. (2008) Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy. Brain Res. Rev. 59, 4254.
  • Scharla S. H., Strong D. D., Mohan S., Baylink D. J. and Linkhart T. A. (1991) 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129, 31393146.
  • Schreiber V., Dantzer F., Ame J. C. and De Murcia G. (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7, 517528.
  • Schwartz M., Zlotorynski E. and Kerem B. (2006) The molecular basis of common and rare fragile sites. Cancer Lett. 232, 1326.
  • Scott T. M., Tucker K. L., Bhadelia A. et al. (2004) Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am. J. Geriatr. Psychiatry 12, 631638.
  • Seder R. A. and Mosmann T. M. (1999) Differentiation of effector phenotypes of CD4+ and CD8+ T cells, in Fundamental Immunology, 4th edn (PaulW. E., ed), pp. 879908. Lippincott-Raven Publisher, Philadelphia.
  • Sen C. K., Khanna S. and Roy S. (2004) Tocotrienol. The natural vitamin E to defend the nervous system? Ann. N Y Acad. Sci. 1031, 127142.
  • Shany S., Levy Y. and Lahav-Cohen M. (2001) The effects of 1α,24(S)-dihydroxyvitamin D2 analog on cancer cell proliferation and cytokine expression. Steroids 66, 319325.
  • Smith F. (2003) The molecular genetics of keratin disorders. Am. J. Clin. Dermatol. 4, 347364.
  • Smolders J., Damoiseaux J., Menheere P. and Hupperts R. (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroimmunol. 194, 717.
  • Snodgrass S. R. (1992) Vitamin neurotoxicity. Mol. Neurobiol. 6, 4173.
  • Son E. W., Mo S. J., Rhee D. K. and Pyo S. (2004) Vitamin C blocks TNF-α-induced NF-κB activation and ICAM-1 expression in human neuroblastoma cells. Arch. Pharm. Res. 27, 10731079.
  • Southam E., Thomas P. K., King R. H., Goss-Sampson M. A. and Muller D. P. (1991) Experimental vitamin E deficiency in rats. Brain 114, 915936.
  • Spector R. and Johanson C. E. (2007) Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J. Neurochem. 103, 425438.
  • Sriram G., Martinez J. A., McCabe E. R., Liao J. C. and Dipple K. M. (2005) Single-gene disorders: what role could moonlighting enzymes play? Am. J. Hum. Genet. 76, 911924.
  • Staeva-Vieira T. and Freedman L. P. (2002) 1,25-Dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 168, 11811189.
  • Stein G. S., Lian J. B., Stein J. L., Van Wijnen A. J. and Montecino M. (1996) Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76, 593629.
  • Steinman L. (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9, 440447.
  • Su S. J., Huang L. W., Pai L. S., Liu H. W. and Chang K. L. (2005) Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 21, 9941002.
  • Suttie J. W. (1993) Synthesis of vitamin K-dependent proteins. FASEB J. 7, 445452.
  • Suzuki M. M. and Bird A. (2008) DNA methylation landscapes: provocative insight from epigenomics. Nat. Rev. Genet. 9, 465476.
  • Suzuki Y. J. and Packer L. (1993) Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193, 277283.
  • Tafti M. and Ghyselinck N. B. (2007) Functional implication of the vitamin A signaling pathway in the brain. Arch. Neurol. 64, 17061711.
  • Takei Y. and Laskey R. (2008) Interpreting crosstalk between TNF-α and NGF: potential implications for disease. Trends Mol. Med. 14, 381388.
  • Tan P. H., Sagoo P., Chan C., Yates J. B., Campbell J., Beutelspacher S. C., Foxwell B. M., Lombardi G. and George A. J. (2005) Inhibition of NF-κB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. 174, 76337644.
  • Tobler A., Gasson J., Reichel H., Norman A. W. and Koeffler H. P. (1987) Granulocyte-macrophage colony-stimulating factor. J. Clin. Invest. 79, 17001705.
  • Tobler A., Miller C. W., Norman A. W. and Koeffler H. P. (1988) 1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J. Clin. Invest. 81, 18191823.
  • Towfighi J. (1981) Effects of chronic vitamin E deficiency on the nervous system of the rat. Acta Neuropathol. 54, 261267.
  • Toyosawa T., Suzuki M., Kodama K. and. and Araki S. (2004) Potentiation by amino acid of the therapeutic effect of highly purified vitamin B2 in mice with lipopolysaccharide-induced shock. Eur. J. Pharmacol. 493, 177182.
  • Tsaioun K. I. (1999) Vitamin K-dependent proteins in the developing and aging nervous system. Nutr. Rev. 57, 231240.
  • Tse A. K. W., Wan C. K., Shen X. L., Zu G. Y., Cheung H. Y., Yang M. and Fong W. F. (2007) 1,25-dihydroxyvitamin D3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB. Exp. Cell Res. 313, 17221734.
  • Twiss J. L., Chang J. H. and Schanen N. C. (2006) Pathophysiological mechanisms for actions of the neurotrophins. Brain Pathol. 16, 320332.
  • Ueno T., Suita S. and Zaizen Y. (1993) Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line. Cancer Lett. 71, 177182.
  • Ulrey C. L., Liu L., Andrews L. G. and Tollefsbol T. O. (2005) The impact of metabolism on DNA methylation. Hum. Mol. Genet. 14, R139R147.
  • Umapathi T. and Chaudhry V. (2005) Toxic neuropathy. Curr. Opin. Neurol. 18, 574580.
  • Ungvari Z., Csiszar A., Edwards J. G., Kaminski P. M., Wolin M. S., Kaley G. and Koller A. (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 23, 418424.
  • Van den Veyver I. B. (2002) Genetic effects of methylation diets. Annu. Rev. Nutr. 22, 255282.
  • Van Wagoner N. J. and Benveniste E. N. (1999) Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100, 124139.
  • Veber D., Mutti E., Galmozzi E., Cedrola S., Galbiati S., Morabito A., Tredici G., La Porta C. A. and Scalabrino G. (2006) Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy. J. Neuroimmunol. 176, 2433.
  • Veber D., Mutti E., Tacchini L., Gammella E., Tredici G. and Scalabrino G. (2008) Indirect downregulation of nuclear NF-κB levels by cobalamin in spinal cord and liver of the rat. J. Neurosci. Res. 86, 13801387.
  • Vermeer C. and Schurgers L. J. (2000) A comprehensive review of vitamin K and vitamin K antagonists. Hematol. Oncol. Clin. North Am. 14, 339353.
  • Villacorta L., Graça-Souza A. V., Ricciarelli R., Zingg J. M. and Azzi A. (2003) α-Tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-α-mediated downregulation in human smooth muscle cells. Circ. Res. 92, 104110.
  • Walz T. M., Malm C., Nishikawa B. K., Willander K., Wingren S. and Wasteson A. (1995) Production of transforming growth factor alpha by human leukemia cells (HL-60 and U-937) during monocytic differentiation. Leukemia 9, 671676.
  • Wang Q. J., Giri S. N., Hyde D. M., Nakashima J. M. and Javadi I. (1990) Niacin attenuates bleomycin-induced lung fibrosis in the hamster. J. Biochem. Toxicol. 5, 1322.
  • Wang G., Siow Y. L. and Karmin O. (2000) Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem. J. 352, 817826.
  • Wang G., Siow Y. L. and Karmin O. (2001) Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-κB in THP-1 macrophages. Am. J. Physiol. Heart Circ. Physiol. 280, H2840H2847.
  • Weima S. M., Rooijen M. A., Mummery C. L., Feijen A., Kruijer W., De Laat S. W. and Van Zoelen E. J. (1988) Differentially regulated production of platelet-derived growth factor and of transforming growth factor beta by a human teratocarcinoma cell line. Differentiation 38, 203210.
  • Weller I. (2001) Secondary immunodeficiency, in Immunology, 6th edn., (RoittI. M., BrostoffJ. and MaleD., eds), pp. 313322. Harcourt Publishers Limited, London.
  • Weninger W., Rendl M., Mildner M. and Tschachler E. (1998) Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J. Invest. Dermatol. 111, 907911.
  • Whitfield G. K., Hsieh J. C., Jurutka P. W., Selznick S. H., Haussler C. A., MacDonald P. N. and Haussler M. R. (1995) Genomic actions of 1,25-dihydroxyvitamin D3. J. Nutr. 125, S1690S1694.
  • Wiedmann S., Eudy J. D. and Zempleni J. (2003) Biotin supplementation increases expression of genes encoding interferon-γ, interleukin-1β, and 3-methylcrotonyl-CoA carboxylase, and decreases expression of the gene encoding interleukin-4 in human peripheral blood mononuclear cells. J. Nutr. 133, 716719.
  • Wilson A. S., Power B. E. and Molloy P. L. (2007) DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775, 138162.
  • Wion D., MacGrogan D., Neveu I., Jehan F., Houlgatte R. and Brachet P. (1991) 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J. Neurosci. Res. 28, 110114.
  • Wu Y., Haugen J. D., Zinsmeister A. R. and Kumar R. (1997) 1α,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. Biochem. Biophys. Res. Commun. 239, 734739.
  • Yamamoto H., Schoonjans K. and Auwerx J. (2007) Sirtuin functions in health and disease. Mol. Endocrinol. 21, 17451755.
  • Yanaka N., Koyama T. A., Komatsu S., Nakamura E., Kanda M. and Kato N. (2005) Vitamin B6 suppresses NF-κB activation in LPS-stimulated mouse macrophages. Int. J. Mol. Med. 16, 10711075.
  • Ylikomi T., Laaksi I., Lou Y. R. et al. (2002) Antiproliferative action of vitamin D. Vitam. Horm. 64, 357406.
  • Yu X. P., Bellido T. and Manolagas S. C. (1995) Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc. Natl Acad. Sci. USA 92, 1099010994.
  • Zawia N. H., Lahiri D. K. and Cardozo-Pelaez F. (2009) Epigenetics, oxidative stress, and Alzheimer disease. Free Radic. Biol. Med. 46, 12411249.
  • Zempleni J., Helm R. M. and Mock D. M. (2001) In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release. J. Nutr. 131, 14791484.
  • Zempleni J., Rucker R. B., McCormick D. B. and Suttie J. W. (2007) Handbook of Vitamins, 4th edn. CRC Press, Boca Raton.